8-KShareholder Matters

GE HealthCare Technologies Inc. 8-K Report, Shareholder Vote Results (May 25, 2023)

Filed May 25, 2023For Securities:GEHC

Summary

GE HealthCare Technologies Inc. (GEHC) filed an 8-K on May 25, 2023, reporting the final voting results from its annual meeting of stockholders held on May 23, 2023. The meeting saw high participation with over 398 million shares present or represented, establishing a quorum. The primary focus for investors is the overwhelming approval of all key proposals, indicating strong shareholder support for the company's current direction and governance. Key outcomes include the election of all 10 director nominees to serve until the 2024 annual meeting, the approval of executive compensation in an advisory vote, and the ratification of Deloitte & Touche LLP as the independent auditor for fiscal year 2023. Furthermore, shareholders overwhelmingly favored holding advisory votes on executive compensation on an annual basis. These results reflect shareholder confidence in the board's leadership and the company's financial oversight.

Key Highlights

  • 1All 10 director nominees were overwhelmingly elected to serve one-year terms until the 2024 annual meeting.
  • 2Shareholders approved the company's named executive officers' compensation via an advisory vote with substantial "For" support.
  • 3An overwhelming majority of shareholders voted in favor of holding advisory votes on executive compensation annually.
  • 4The appointment of Deloitte & Touche LLP as the independent auditor for the fiscal year ending December 31, 2023, was ratified.
  • 5A quorum of 398,069,569 shares of common stock was present or represented at the annual meeting, indicating strong shareholder engagement.
  • 6Director nominees received a very high percentage of 'Votes For', generally exceeding 99% of votes cast, excluding broker non-votes.

Frequently Asked Questions

The main outcomes include the election of all 10 director nominees, the approval of executive compensation in an advisory vote, the decision to hold future advisory votes on executive compensation annually, and the ratification of Deloitte & Touche LLP as the independent auditor for fiscal year 2023. All proposals received strong shareholder support.

Shareholders overwhelmingly elected all 10 director nominees. For example, Peter J. Arduini received 357,184,541 'Votes For' out of approximately 360 million cast, indicating strong confidence in the current board leadership.

Following the vote at the annual meeting, GE HealthCare's Board of Directors has determined that future advisory votes on executive compensation will be submitted to stockholders on an annual basis. This aligns with the preference indicated by the majority of shareholders who voted.

The appointment of Deloitte & Touche LLP as GE HealthCare's independent auditor for the fiscal year ending December 31, 2023, was ratified by the shareholders, with a very high percentage of 'Votes For'.